Orthocell Limited
ASX:OCC.AX
0.64 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.315 | 4.243 | 1.532 | 1.018 | 0.72 | 0.946 | 0.619 | 0.53 | 0.666 | 0.79 | 0.691 | 0.524 |
| Cost of Revenue
| 1.659 | 1.182 | 0.699 | 0.718 | 0.726 | 0.732 | 0.47 | 0.438 | 0.498 | 0.653 | 0.597 | 0.482 |
| Gross Profit
| 3.656 | 3.061 | 0.833 | 0.3 | -0.006 | 0.213 | 0.149 | 0.092 | 0.169 | 0.138 | 0.094 | 0.042 |
| Gross Profit Ratio
| 0.688 | 0.721 | 0.544 | 0.295 | -0.009 | 0.226 | 0.241 | 0.173 | 0.253 | 0.174 | 0.136 | 0.08 |
| Reseach & Development Expenses
| 8.674 | 7.598 | 6.818 | 7.343 | 5.47 | 5.585 | 4.635 | 3.914 | 3.369 | 0.733 | 0.686 | 0.451 |
| General & Administrative Expenses
| 3.61 | 4.25 | 2.237 | 3.254 | 2.558 | 2.018 | 2.022 | 1.785 | 1.602 | 0.895 | 0.498 | 0.416 |
| Selling & Marketing Expenses
| 3.085 | 1.709 | 3.298 | 1.465 | 1.442 | 1.284 | 1.786 | 1.065 | 0.984 | 0.971 | 0.572 | 0.525 |
| SG&A
| 6.663 | 5.773 | 5.539 | 4.626 | 3.993 | 3.302 | 3.807 | 2.85 | 2.586 | 5.118 | 2.665 | 2.149 |
| Other Expenses
| 0.417 | 0.079 | 0.19 | 0.039 | 0.083 | 0.141 | 0.265 | 0.511 | 0.459 | 0.777 | 1.108 | 0 |
| Operating Expenses
| 15.337 | 13.371 | 12.357 | 11.969 | 9.463 | 8.605 | 8.177 | 6.253 | 5.523 | 5.161 | 2.822 | 1.39 |
| Operating Income
| -11.681 | -10.31 | -11.525 | -11.669 | -9.469 | -8.516 | -8.032 | -6.164 | -5.354 | -5.024 | -2.728 | -1.348 |
| Operating Income Ratio
| -2.198 | -2.43 | -7.524 | -11.463 | -13.161 | -9.006 | -12.972 | -11.635 | -8.034 | -6.356 | -3.945 | -2.571 |
| Total Other Income Expenses Net
| 1.449 | 0.899 | 0.274 | 0.238 | 0.414 | 0.136 | 0.023 | 0.039 | 0.062 | 0.123 | 0.015 | 0.025 |
| Income Before Tax
| -10.232 | -9.411 | -11.251 | -11.431 | -9.056 | -8.38 | -8.009 | -6.125 | -5.293 | -4.901 | -2.713 | -1.323 |
| Income Before Tax Ratio
| -1.925 | -2.218 | -7.345 | -11.23 | -12.586 | -8.862 | -12.935 | -11.561 | -7.941 | -6.2 | -3.923 | -2.524 |
| Income Tax Expense
| -3.051 | -3.162 | -2.144 | -2.394 | -2.905 | 2.528 | 2.252 | 1.948 | 1.508 | 1.158 | 0.53 | 0 |
| Net Income
| -7.181 | -6.248 | -9.107 | -9.037 | -6.151 | -5.852 | -5.757 | -4.177 | -3.785 | -3.743 | -2.182 | -1.323 |
| Net Income Ratio
| -1.351 | -1.473 | -5.945 | -8.878 | -8.549 | -6.189 | -9.298 | -7.885 | -5.679 | -4.735 | -3.156 | -2.524 |
| EPS
| -0.036 | -0.032 | -0.047 | -0.048 | -0.036 | -0.049 | -0.055 | -0.043 | -0.043 | -0.05 | -0.062 | -0.038 |
| EPS Diluted
| -0.036 | -0.032 | -0.047 | -0.048 | -0.036 | -0.049 | -0.055 | -0.043 | -0.043 | -0.05 | -0.062 | -0.038 |
| EBITDA
| -11.164 | -9.756 | -11.176 | -11.234 | -9.209 | -8.298 | -7.839 | -6.017 | -5.254 | -4.965 | -2.69 | -1.303 |
| EBITDA Ratio
| -2.1 | -2.299 | -7.296 | -11.035 | -12.799 | -8.774 | -12.66 | -11.356 | -7.883 | -6.281 | -3.89 | -2.486 |